
Opioid use disorder often leads to criminal justice involvement. 1 We describe the initiation and growth of this program with the hope that other jurisdictions will develop similar programs.

In the first year of this program’s implementation, there was a 12% drop in statewide overdose deaths and a 61% drop in postincarceration overdose deaths.

In 2016, the Rhode Island Department of Corrections (RIDOC) became the first state correctional system to initiate a comprehensive program to screen all individuals for opioid use disorder, to offer treatment with all three Food and Drug Administration–approved medications (i.e., methadone, buprenorphine, and naltrexone) to medically eligible incarcerated people, and to provide linkage to care in the community after release.
